Hints and tips:
...Eli Lilly’s tirzepatide drug had less than 10 per cent absolute weight reduction at all doses after its late-stage trial, noted Thomas Smith, an analyst at Leerink Partners....
...Eli Lilly is racing to secure the services of outsourcers to boost production of its obesity drug Zepbound, as the US pharmaceutical group rolls out its rival to Danish group Novo Nordisk’s blockbuster appetite...
...Here’s what else I’m keeping tabs on today: Results: Eli Lilly, the maker of weight loss drug Mounjaro, reports this morning alongside KKR, Spotify, GE Healthcare and Hertz....
...Other drugmakers could still “win” the race in the rapidly growing obesity market dominated by Novo Nordisk and Eli Lilly, according to the chief executive of biotech company Zealand Pharma....
...Obesity drugs: Weight-loss treatments are tipped to rake in $80bn a year by 2030, but smaller companies will struggle to break into a market led by Novo Nordisk and Eli Lilly....
...Results: Apple, Eli Lilly, ConocoPhillips, Fox, Starbucks, S&P Global, Moderna, Shopify and Paramount Global will report before the market opens....
...Chart of the day Inspired by tales of celebrities’ dramatic weight loss, a new generation of drugs such as Novo Nordisk’s Wegovy, Ozempic and the soon to be launched Mounjaro from Eli Lilly are becoming...
...Results: Eli Lilly, UPS, Under Armour, Warner Music, Fox Corporation, Rivian, AMC Entertainment, Duolingo, Lyft and Bumble all report earnings today....
...Dementia experts have hailed the latest landmark in the treatment of Alzheimer’s after Eli Lilly released trial results that showed its new drug significantly slowed memory loss and cognitive decline....
...Results: Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb report results today, as do Southwest Airlines, Caterpillar and Honeywell....
...Eli Lilly is to apply for regulatory approval for an Alzheimer drug that a clinical study showed could slow the progress of cognitive decline in patients in the early stages....
...The show’s editor is Jess Smith. Additional help by Peter Barber, Michael Lello, David da Silva and Gavin Kallmann. Topher Forhecz is the FT’s executive producer....
...Pharmaceutical companies Eli Lilly, Merck and Bristol Myers Squibb also report....
...figures Germany: final July consumer price index (CPI) and harmonised index of consumer prices (HICP) inflation rate data UK: BRC-KPMG Retail Sales Monitor Results: Abrdn H1, Bayer Q2, Duke Energy Q2, Eli...
...Our editor is Jess Smith. With help this week from Eli Meixler, David da Silva, Michael Lello and Gavin Kallmann. Our executive producer is Topher Forhecz....
...Eli Lilly will join Pfizer in reporting before the opening bell....
...Morgan Stanley is reorganising its top leadership in investment banking, with Eli Gross and Simon Smith elevated to co-heads of the division, and current bosses Mark Eichorn and Susie Huang becoming executive...
...Walden Macht & HaranO: 6; L: 8; I: 7; Total: 21The firm represented Ronald Streck, a whistleblower against pharmaceutical group Eli Lilly, in a series of successful False Claims Act lawsuits....
...Among the others reporting are McDonald's, Merck, Comcast, Southwest and Eli Lilly....
...Coronavirus digest The US drugs regulator has rescinded its authorisation for the monoclonal antibody treatments made by Eli Lilly and Regeneron, which do not work well against the Omicron variant....
...Job moves Morgan Stanley has promoted Eli Gross and Simon Smith to co-heads of its investment banking division. They replace Mark Eichorn and Susie Huang, who will become executive chairs....
...risks for public services in England US, Q1 GDP estimate plus Q1 consumer spending figures Results: Amazon.com Q1, Apple Q2, Barclays Q1, Carlsberg Group Q1 trading statement, Caterpillar Q1, Comcast Q1, Eli...
...Our editor is Jess Smith. We had help this week from Eli Meixler, Joanna Kao, George Drake Jr, David Dasilva, Peter Barber and Gavin Kallmann. Our executive producer is Topher Forhecz....
Your daily briefing on the news
International Edition